Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sabesp

20.76
-0.3400-1.61%
Post-market: 20.760.00000.00%17:01 EDT
Volume:1.22M
Turnover:25.51M
Market Cap:14.19B
PE:7.95
High:21.09
Open:21.07
Low:20.74
Close:21.10
Loading ...

Exit Polls Show Lee Sun-mi Will Win South Korea's Presidential Election

Blockbeats
·
03 Jun

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome

GlobeNewswire
·
02 Jun

SABESP Files SEC Report to Maintain Regulatory Compliance

TIPRANKS
·
30 May

SBS Transit Announces Board Restructuring Amid Leadership Changes

TIPRANKS
·
26 May

Tampines Changkat MP Desmond Choo resigns from SBS Transit’s board after Cabinet appointment

businesstimes
·
26 May

SABESP Announces New Head of Investor Relations

TIPRANKS
·
23 May

SABESP Reports Strong Financial Growth in 2024 with New Concession Agreement

TIPRANKS
·
23 May

SABESP Announces Share Buyback Plan to Enhance Capital Structure

TIPRANKS
·
20 May

South Korean Actor Joohyun Huang Accused of Embezzling Around $3 Million Investment in Cryptocurrency

Blockbeats
·
20 May

SABESP Files 2024 Form 20-F with SEC

TIPRANKS
·
17 May

SBS Holdings Inc Sees 1H Net Y3.20B

Dow Jones
·
14 May

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Press Release: Entera Bio Announces First Quarter 2025 Financial Results and Business Updates

Dow Jones
·
10 May

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP expected to post earnings of R$2.20 a share - Earnings Preview

Reuters
·
10 May

SABESP Releases 2024 Financial Statements with Strong Asset Base

TIPRANKS
·
07 May

Press Release: Standard BioTools Reports First Quarter 2025 Financial Results

Dow Jones
·
07 May

Proof-of-Concept Results Show Crofelemer Reduced Total Parenteral Nutrition in Patients with Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) by up to 27% and 12.5% - Potential to Modify Disease Progression in Intestinal Failure Patients

ACCESS Newswire
·
30 Apr

Here's Why We're Wary Of Buying SBS Transit's (SGX:S61) For Its Upcoming Dividend

Simply Wall St.
·
30 Apr

SABESP Updates Bylaws to Strengthen Governance

TIPRANKS
·
30 Apr

Is Evergy (EVRG) Stock Outpacing Its Utilities Peers This Year?

Zacks
·
29 Apr